[1]CurrentPatentAssignee:APRINOIATHERAPEUTICSCN-WO2019/214681,2019,A1Locationinpatent:Paragraph0305;0308-0309;0377;0380-0381
73290-22-9
1810-74-8 | 7-Methoxy-2,2,4-trimethyl-1,2-dihydroquinoline | AA0022GQ | MFCD00627122
181228-33-1 | (S)-Methyl 3-amino-2-((tert-butoxycarbonyl)amino)propanoate hydrochloride | AA0022O5 | MFCD04973085
18174-72-6 | Muscimol hydrobromide | AA0022ZV | MFCD00055184
1820648-87-0 | Sodium 2-(pyrimidin-4-yl)acetate | AA00238M | MFCD28096656
182349-12-8 | (2E)-but-2-enedioic acid; 13-chloro-2-{1-[(5-methylpyridin-3-yl)methyl]piperidin-4-ylidene}-4-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaene | AA0023LU | MFCD00926499
1826900-79-1 | Bicyclo[1.1.1]pentan-1-amine, 3-fluoro-, hydrochloride (1:1) | AA0023ZH | MFCD28963742
17617-34-4 | Sodium 2-(2-aminophenyl)-2-oxoacetate | AA0024DO | MFCD20694501
176652-07-6 | 3,12-Epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10(3H)-one, octahydro-3,6-dimethyl-9-(methyl-d3)-, [3R-(3α,5aβ,6β,8aβ,9α,12β,12aR*)]- (9CI) | AA0024Q4 | MFCD09952132
177-17-3 | 6-Azaspiro[4.5]decane (8CI,9CI) | AA0024ZU | MFCD09035904
1775-37-7 | Acetamide, N-[4-[(4-nitrophenyl)sulfonyl]phenyl]- | AA0025A8 | MFCD00024704
